HeartSciences Inc (HSCS)
HeartSciences Inc. is a healthcare company focused on medical technology for electrocardiography, with an emphasis on artificial intelligence-enabled ECG solutions. The company develops AI-ECG tools intended to help detect impaired cardiac relaxation or cardiac dysfunction. Its product lineup includes MyoVista wavECG, a resting 12-lead ECG device designed to provide diagnostic information related to cardiac dysfunction alongside conventional ECG data, and MyoVista Insights, a cloud-based ECG management platform that is vendor- and device-agnostic. Formerly known as Heart Test Laboratories, Inc., the company adopted the HeartSciences Inc. name in October 2024. Incorporated in 2007, it is headquartered in Southlake, Texas. The common stock is listed on the NASDAQ exchange under the ticker HSCS.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-HSCS
|
$1.91
|
-16.1% Downside
|
Fair
|
$10
|
338.6% Upside
|
Bargain
|
Weak
|
—
|
—
|
—
|
0.0%
|
September 10, 2026
|
-1.0x
|
39.5x
|
2,058.5x
|
8.111 M
|
11.172 M
|
32.1%
|
80.4%
|
-50.9
|
—
|
81.3%
|
